{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:26:47Z","timestamp":1795231607943,"version":"4.10.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regionala forskningsr\u00e5det i Uppsala-\u00d6rebroregionen (RFR in Uppsala-\u00d6rebro)"},{"name":"Vetenskapsr\u00e5det funding for clinical research in medicine (ALF) in V\u00e4sterbotten"},{"DOI":"10.13039\/501100002960","name":"V\u00e4sterbotten L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002960","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Research Foundation in Northern Sweden (SE)"},{"name":"Stiftelsen Emil Anderssons fond f\u00f6r Medicinsk forskning"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13148-018-0536-6","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T10:24:55Z","timestamp":1533291895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6957-7129","authenticated-orcid":false,"given":"Emma","family":"Ahl\u00e9n Bergman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciputra Adijaya","family":"Hartana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvig B.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hyllienmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Holmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhood","family":"Alamdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Huge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Aljabery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Riklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin E.","family":"Winerdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ali","family":"Zirakzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Marits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise K.","family":"Sj\u00f6holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Winqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"issue":"2","key":"536_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2014.10.001","volume":"29","author":"N Malats","year":"2015","unstructured":"Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 2015;29(2):177\u201389, vii.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"536_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"536_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"3","key":"536_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00345-007-0168-5","volume":"25","author":"C Murta-Nascimento","year":"2007","unstructured":"Murta-Nascimento C, et al. Epidemiology of urinary bladder cancer: from tumor development to patient\u2019s death. World J Urol. 2007;25(3):285\u201395.","journal-title":"World J Urol"},{"issue":"1","key":"536_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/cas.12075","volume":"104","author":"K Kawai","year":"2013","unstructured":"Kawai K, et al. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci. 2013;104(1):22\u20137.","journal-title":"Cancer Sci"},{"issue":"10","key":"536_CR6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","volume":"108","author":"ME Winerdal","year":"2011","unstructured":"Winerdal ME, et al. FOXP3 and survival in urinary bladder cancer. BJU Int. 2011;108(10):1672\u20138.","journal-title":"BJU Int"},{"issue":"10","key":"536_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/sj.bjc.6603126","volume":"94","author":"P Marits","year":"2006","unstructured":"Marits P, et al. Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer. Br J Cancer. 2006;94(10):1478\u201384.","journal-title":"Br J Cancer"},{"issue":"1","key":"536_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2005.09.010","volume":"49","author":"P Marits","year":"2006","unstructured":"Marits P, et al. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol. 2006;49(1):59\u201370.","journal-title":"Eur Urol"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.immunol.21.120601.141107","volume":"21","author":"TK Starr","year":"2003","unstructured":"Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139\u201376.","journal-title":"Annu Rev Immunol"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445\u201389.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"536_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1084\/jem.183.3.901","volume":"183","author":"E Murphy","year":"1996","unstructured":"Murphy E, et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med. 1996;183(3):901\u201313.","journal-title":"J Exp Med"},{"issue":"2","key":"536_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.184.2.473","volume":"184","author":"T Sornasse","year":"1996","unstructured":"Sornasse T, et al. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med. 1996;184(2):473\u201383.","journal-title":"J Exp Med"},{"issue":"18","key":"536_CR13","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1073\/pnas.192263099","volume":"99","author":"M Ahmadzadeh","year":"2002","unstructured":"Ahmadzadeh M, Farber DL. Functional plasticity of an antigen-specific memory CD4 T cell population. Proc Natl Acad Sci U S A. 2002;99(18):11802\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"536_CR14","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.4049\/jimmunol.171.7.3542","volume":"171","author":"MS Sundrud","year":"2003","unstructured":"Sundrud MS, et al. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J Immunol. 2003;171(7):3542\u20139.","journal-title":"J Immunol"},{"issue":"8","key":"536_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ni.1899","volume":"11","author":"KM Murphy","year":"2010","unstructured":"Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol. 2010;11(8):674\u201380.","journal-title":"Nat Immunol"},{"issue":"9","key":"536_CR16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/eji.200737594","volume":"37","author":"U Baron","year":"2007","unstructured":"Baron U, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol. 2007;37(9):2378\u201389.","journal-title":"Eur J Immunol"},{"issue":"2","key":"536_CR17","doi-asserted-by":"publisher","first-page":"e1612","DOI":"10.1371\/journal.pone.0001612","volume":"3","author":"PC Janson","year":"2008","unstructured":"Janson PC, et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS One. 2008;3(2):e1612.","journal-title":"PLoS One"},{"issue":"4","key":"536_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.immuni.2006.03.007","volume":"24","author":"GR Lee","year":"2006","unstructured":"Lee GR, et al. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity. 2006;24(4):369\u201379.","journal-title":"Immunity"},{"issue":"1","key":"536_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4049\/jimmunol.1000960","volume":"186","author":"PC Janson","year":"2011","unstructured":"Janson PC, et al. Profiling of CD4+ T cells with epigenetic immune lineage analysis. J Immunol. 2011;186(1):92\u2013102.","journal-title":"J Immunol"},{"issue":"4","key":"536_CR20","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.4049\/jimmunol.181.4.2878","volume":"181","author":"PC Janson","year":"2008","unstructured":"Janson PC, et al. CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. J Immunol. 2008;181(4):2878\u201386.","journal-title":"J Immunol"},{"issue":"4","key":"536_CR21","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.4049\/jimmunol.169.4.1893","volume":"169","author":"S Santangelo","year":"2002","unstructured":"Santangelo S, et al. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation. J Immunol. 2002;169(4):1893\u2013903.","journal-title":"J Immunol"},{"issue":"3","key":"536_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0022-5347(05)65842-9","volume":"166","author":"A Sherif","year":"2001","unstructured":"Sherif A, et al. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol. 2001;166(3):812\u20135.","journal-title":"J Urol"},{"issue":"11","key":"536_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/bioinformatics\/16.11.1046","volume":"16","author":"C Mayor","year":"2000","unstructured":"Mayor C, et al. VISTA : visualizing global DNA sequence alignments of arbitrary length. Bioinformatics. 2000;16(11):1046\u20137.","journal-title":"Bioinformatics"},{"issue":"3","key":"536_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cei.12060","volume":"172","author":"J Hu","year":"2013","unstructured":"Hu J, et al. The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation. Clin Exp Immunol. 2013;172(3):490\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"536_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","volume":"61","author":"R Rosenblatt","year":"2012","unstructured":"Rosenblatt R, et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer. Eur Urol. 2012;61(6):1229\u201338.","journal-title":"Eur Urol"},{"issue":"3","key":"536_CR26","first-page":"167","volume":"780","author":"AL Pinto","year":"1985","unstructured":"Pinto AL, Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta. 1985;780(3):167\u201380.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"536_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0163-7258(87)90009-X","volume":"34","author":"A Eastman","year":"1987","unstructured":"Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther. 1987;34(2):155\u201366.","journal-title":"Pharmacol Ther"},{"issue":"Suppl","key":"536_CR28","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1007\/PL00014051","volume":"46","author":"T Nishimura","year":"2000","unstructured":"Nishimura T, et al. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol. 2000;46(Suppl):S52\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"536_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","volume":"65","author":"JA Witjes","year":"2014","unstructured":"Witjes JA, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65(4):778\u201392.","journal-title":"Eur Urol"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2016.12.003","volume":"176","author":"AA Zirakzadeh","year":"2017","unstructured":"Zirakzadeh AA, et al. Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. Clin Immunol. 2017;176:63\u201370.","journal-title":"Clin Immunol"},{"issue":"24","key":"536_CR31","doi-asserted-by":"publisher","first-page":"13791","DOI":"10.1073\/pnas.93.24.13791","volume":"93","author":"C Sgadari","year":"1996","unstructured":"Sgadari C, et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci U S A. 1996;93(24):13791\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"536_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett. 2011;2(4):583\u20139.","journal-title":"Oncol Lett"},{"issue":"6","key":"536_CR33","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s11033-009-9873-z","volume":"37","author":"Z Jiang","year":"2010","unstructured":"Jiang Z, Xu Y, Cai S. CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol Biol Rep. 2010;37(6):3029\u201336.","journal-title":"Mol Biol Rep"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-018-0536-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T01:45:09Z","timestamp":1568943909000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-018-0536-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s13148-018-0536-6","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethical committee (original dnr: 2007\/71-31 with latest amendment 2017\/190-32, both EPN-Stockholm).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"102"}}